Novo Nordisk A/S (NVO): Is It Undervalued? Intrinsic Value & Margin of Safety

We calculate the intrinsic value of Novo Nordisk A/S (NVO) using Warren Buffett's method and compare it to the current market price to estimate whether the stock is undervalued or overvalued.

Data as of 2026-09-17 · updated monthly

The method doesn't give a reliable result for this company

• Intrinsic valueUS$ 327.73
• Current priceUS$ 43.12
• Margin of safety—

Model result using data as of 2026-09-17 and a price of US$ 43.12. General information, not advice. See methodology

Intrinsic value is the present value of the cash Novo Nordisk A/S can generate over the rest of its useful life, discounted at the 10-year Treasury yield. We project the historical growth of book value (or EPS for companies with heavy buybacks) over 10 years, apply a historical exit multiple, and discount it back to today, adding dividends. The margin of safety is the gap between that intrinsic value and the market price: the larger and more positive it is, the more protection you have against estimation errors or market drops. A negative margin means the market is already paying more than the business appears to be worth. These figures are educational and do not constitute financial advice.